Antiretroviral News and Research

RSS

GlobalPost series examines HIV/AIDS in European, MENA regions

As part of its ongoing series, titled "The State of AIDS," GlobalPost published two articles examining the epidemic in different regions. In Eastern Europe, rates of HIV/AIDS diagnoses have risen in several countries, including Ukraine and Russia, according to the first article, which discusses some of the potential reasons for the increases.

11 Dec 2012

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

For the first time, Brazil in 2013 will enter into a new type of public-private partnership that allows the nation to produce a generic version of the antiretroviral (ARV) drug atazanavir sulphate, which will be under patent through its producer Bristol-Myers Squibb until 2017, Inter Press Service reports.

8 Dec 2012

International community should 'not forget' importance of treatment, care for children with HIV

The "progress and momentum" behind stopping mother-to-child HIV transmission is "reason to celebrate," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill's "Congress Blog."

8 Dec 2012

Cost-benefit analysis of TasP compared with circumcision, ART

In a study published online in the Proceedings of the National Academy of Sciences, Till Barnighausen, David Bloom, and Salal Humair of the Harvard School of Public Health examine "whether [HIV treatment as prevention (TasP)] is indeed a game changer or if comparable benefits are obtainable at similar or lower cost by increasing coverage of medical male circumcision (MMC) and antiretroviral treatment (ART)."

8 Dec 2012

Global Post examines unproven, unscientific HIV treatments

Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven -- but more expensive -- therapies, such as antiretroviral (ARV) drugs.

6 Dec 2012

Children with HIV more likely to develop atherosclerosis

Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease.

5 Dec 2012

Starting ART for HIV decreases food insecurity among patients in Uganda

Can treatment with modern anti-HIV drugs help fight hunger for HIV-infected patients in Africa? Starting antiretroviral therapy for HIV reduces "food insecurity" among patients in Uganda, suggests a study published online by the journal AIDS, official journal of the International AIDS Society. AIDS is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

5 Dec 2012

GlobalPost examines HIV/AIDS in Asia, Africa

As part of its series titled "The State of HIV/AIDS," GlobalPost published two stories examining the epidemic in different regions of the world. In one article, the news service looks at the spread and control of HIV in Asia, writing, "No generalized epidemic has broken out across the region, HIV infection rates have stabilized in many countries, and more and more people are receiving antiretroviral medication."

4 Dec 2012

University of Washington team develops electrically spun cloth to prevent pregnancy, HIV

The only way to protect against HIV and unintended pregnancy today is the condom. It's an effective technology, but not appropriate or popular in all situations.

1 Dec 2012

Mother-to-child transmission of HIV can be eliminated through collective alliances

"The global economic crisis has caused many to reassess, refocus and redirect financial priorities," and "as a result, vital international aid to combat global health issues like HIV/AIDS is threatened," Rhonda Zygocki, executive vice president of policy and planning at Chevron Corporation, and Frank Beadle de Palomo, CEO of mothers2mothers International, write in the Huffington Post's "Impact" blog.

30 Nov 2012

More widespread HIV treatment helped South Africa increase life expectancy, researchers say

With the average life expectancy for South Africans at 60 years old, the country "has achieved a 'stunning' increase in life expectancy in the last three years due to a government push to roll out antiretroviral drugs (ARVs) to people with HIV/AIDS," according to a study published in the Lancet on Thursday, Reuters reports.

30 Nov 2012

Secretary Clinton unveils 'blueprint' for achieving 'AIDS-free generation'

"Secretary of State Hillary Clinton on Thursday unveiled a game plan for achieving a global 'AIDS-free generation,' committing the United States to rapidly scaling up medical interventions that are beating back what once was seen as an unconquerable disease," Reuters reports.

30 Nov 2012

AIDS.gov blog publishes posts leading up to World AIDS Day

Leading up to World AIDS Day on December 1, the AIDS.gov blog published several pieces discussing progress in reaching the goal of an AIDS-free generation.

30 Nov 2012

VAC-3S immunotherapeutic vaccine for HIV completes first clinical development phase

InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.

30 Nov 2012

JQ1 cancer drug may be useful in purging latent HIV infection

Breakthrough drugs have made it possible for people to live with HIV longer than ever before, but more work must be done to actually cure the disease. One of the challenges researchers face involves fully eradicating the virus when it is latent in the body.

30 Nov 2012

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for two new indications for once-daily Viread (tenofovir disoproxil fumarate).

28 Nov 2012

Routine HIV testing can reduce illness and death across Canada

Offering routine HIV testing to the general population rather than only to high-risk individuals will significantly reduce illness and death, argues Dr. Julio Montaner and coauthors in an editorial in CMAJ (Canadian Medical Association Journal).

27 Nov 2012

New tool helps identify nonadherent HIV patients

Researchers have developed a simple tool that predicts virologic response and development of drug resistance in patients receiving HIV treatment, based on how regularly they attend their scheduled health appointments.

26 Nov 2012

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

Lymphopenia is when you lack the T cells of your immune system. T cells are very important for controlling infection. Probably the most known cause of lymphopenia is HIV.

23 Nov 2012

UNAIDS report indicates end to AIDS possible but challenges remain

UNAIDS' World AIDS Day report: Results, released on Tuesday, said the goal of eventually ending the global AIDS epidemic "is more than merely visionary" and "is entirely feasible," primarily because of "historic success" in scaling up HIV programs and improving access to antiretroviral drugs to treat and prevent HIV, Reuters reports.

22 Nov 2012

Antiretroviral News and Research

GlobalPost series examines HIV/AIDS in European, MENA regions

New public-private partnership will allow Brazil to produce patented ARV for national treatment program

International community should 'not forget' importance of treatment, care for children with HIV

Cost-benefit analysis of TasP compared with circumcision, ART

Global Post examines unproven, unscientific HIV treatments

Children with HIV more likely to develop atherosclerosis

Starting ART for HIV decreases food insecurity among patients in Uganda

GlobalPost examines HIV/AIDS in Asia, Africa

University of Washington team develops electrically spun cloth to prevent pregnancy, HIV

Mother-to-child transmission of HIV can be eliminated through collective alliances

More widespread HIV treatment helped South Africa increase life expectancy, researchers say

Secretary Clinton unveils 'blueprint' for achieving 'AIDS-free generation'

AIDS.gov blog publishes posts leading up to World AIDS Day

VAC-3S immunotherapeutic vaccine for HIV completes first clinical development phase

JQ1 cancer drug may be useful in purging latent HIV infection

Gilead Sciences receives EC approval for Viread to treat HIV-1 infected children

Routine HIV testing can reduce illness and death across Canada

New tool helps identify nonadherent HIV patients

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

UNAIDS report indicates end to AIDS possible but challenges remain

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News